EyePoint Pharmaceuticals, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$30.8M, a 34.5% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$86.8M, a 18.1% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$70.8M, a 30.8% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$102M, a 75% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$58.4M, a 28.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$70.8M +$31.5M +30.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$102M -$43.8M -75% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$58.4M -$13M -28.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$45.4M +$11.4M +20.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$56.8M +$29.3M +34.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$86.1M -$67.6M -366% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$18.5M +$3.06M +14.2% Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 -$21.5M -$27.9M -439% Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2015 $6.35M +$19.7M Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 -$13.4M -$1.46M -12.2% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 -$11.9M +$12.9M +52.1% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 -$24.8M -$16.2M -188% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-11
2011 -$8.63M -$17.4M -199% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 $8.75M Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.